Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Toyo Pharmar is a Japanese pharmaceutical company specializing in the development, manufacturing, and sale of generic medicines. Headquartered in Toyama, Japan, the company operates as a wholly-owned subsidiary of Nichi-Iko Pharmaceutical Co., Ltd. Its product portfolio covers a broad range of therapeutic areas, including cardiovascular, metabolic, and central nervous system disorders. Toyo Pharmar maintains robust manufacturing facilities capable of producing various dosage forms such as tablets, capsules, and injections. In addition to its proprietary generic line, the company provides contract manufacturing organization (CMO) services to other pharmaceutical entities. The company plays a vital role in the Japanese healthcare market by providing high-quality, cost-effective alternatives to branded pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Toyo Pharmar.